Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. 2010

Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
Department of Emergency and Critical Care Medicine, Aichi Medical University, Nagakute-cho, Aichi, Japan, takaki@aichi-med-u.ac.jp.

OBJECTIVE We evaluated the relations among the arterial carbon monoxide (CO) concentration, heme oxygenase (HO)-1 expression by monocytes, oxidative stress, plasma levels of cytokines and bilirubin, and the outcome of patients with severe sepsis or septic shock. METHODS Thirty-six patients who fulfilled the criteria for severe sepsis or septic shock and 21 other patients without sepsis during their stay in the intensive care unit were studied. HO-1 protein expression by monocytes, arterial CO, oxidative stress, bilirubin, and cytokines were measured. RESULTS Arterial blood CO, cytokine, and bilirubin levels, and monocyte HO-1 protein expression were higher in patients with severe sepsis/septic shock than in non-septic patients. Increased HO-1 expression was related to the arterial CO concentration and oxidative stress. There was a positive correlation between survival and increased HO-1 protein expression or a higher CO level. CONCLUSIONS Arterial CO and monocyte HO-1 protein expression were increased in critically ill patients, particularly those with severe sepsis or septic shock, suggesting that oxidative stress is closely related to HO-1 expression. The HO-1/CO system may play an important role in sepsis.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D008297 Male Males
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D003849 Deoxyguanosine A nucleoside consisting of the base guanine and the sugar deoxyribose.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000080242 8-Hydroxy-2'-Deoxyguanosine Common oxidized form of deoxyguanosine in which C-8 position of guanine base has a carbonyl group. 2'-Deoxy-7,8-Dihydro-8-Oxoguanosine,2'-Deoxy-8-Hydroxyguanosine,2'-Deoxy-8-Oxo-7,8-Dihydroguanosine,2'-Deoxy-8-Oxoguanosine,7,8-Dihydro-8-Oxo-2'-Deoxyguanosine,7-Hydro-8-Oxodeoxyguanosine,8-Hydroxydeoxyguanosine,8-Oxo-2'-Deoxyguanosine,8-Oxo-7,8-Dihydro-2'-Deoxyguanosine,8-Oxo-7,8-Dihydrodeoxyguanosine,8-Oxo-7-Hydrodeoxyguanosine,8-Oxo-Deoxyguanosine,8OHdG,8-OH-dG,8-oxo-dG,8-oxo-dGuo,8-oxodG,8-oxodGuo,2' Deoxy 7,8 Dihydro 8 Oxoguanosine,2' Deoxy 8 Hydroxyguanosine,2' Deoxy 8 Oxo 7,8 Dihydroguanosine,2' Deoxy 8 Oxoguanosine,7 Hydro 8 Oxodeoxyguanosine,7,8 Dihydro 8 Oxo 2' Deoxyguanosine,8 Hydroxy 2' Deoxyguanosine,8 Hydroxydeoxyguanosine,8 Oxo 2' Deoxyguanosine,8 Oxo 7 Hydrodeoxyguanosine,8 Oxo 7,8 Dihydro 2' Deoxyguanosine,8 Oxo 7,8 Dihydrodeoxyguanosine,8 Oxo Deoxyguanosine
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
December 2009, Irish journal of medical science,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
June 2001, American journal of hypertension,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
December 2007, Antioxidants & redox signaling,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
January 2003, Respiratory research,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
August 2009, Interactive cardiovascular and thoracic surgery,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
September 2003, American journal of physiology. Regulatory, integrative and comparative physiology,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
January 2005, Proceedings of the American Thoracic Society,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
January 2008, The Journal of clinical investigation,
Shoji Takaki, and Naoshi Takeyama, and Yuka Kajita, and Teru Yabuki, and Hiroki Noguchi, and Yasuo Miki, and Yasusuke Inoue, and Takashi Nakagawa, and Hiroshi Noguchi
February 2007, The Journal of clinical investigation,
Copied contents to your clipboard!